Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review

被引：0
|
作者：
Francesco Spagnolo
Andrea Boutros
Federica Cecchi
Elena Croce
Enrica Teresa Tanda
Paola Queirolo
机构：
[1] IRCCS Ospedale Policlinico San Martino,Medical Oncology 2
[2] European Institute of Oncology (IEO),Melanoma, Sarcoma & Rare Tumors Division
来源：
BMC Cancer | / 21卷
关键词：
Melanoma; Immunotherapy; Immune-related response criteria; Treatment beyond progression; Anti-PD-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review
    Spagnolo, Francesco
    Boutros, Andrea
    Cecchi, Federica
    Croce, Elena
    Tanda, Enrica Teresa
    Queirolo, Paola
    BMC CANCER, 2021, 21 (01)
  • [2] A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors
    Martorana, F.
    Colombo, I.
    Treglia, G.
    Gillessen, S.
    Stathis, A.
    CANCER TREATMENT REVIEWS, 2021, 101
  • [3] Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review
    Zhang, Yiru
    Yao, Qigu
    Pan, Yong
    Fang, Xinru
    Xu, Haoying
    Zhao, Tingxiao
    Zhu, Guangqi
    Jiang, Tianan
    Li, Shibo
    Cao, Hongcui
    CANCERS, 2023, 15 (03)
  • [4] Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis
    Han Li
    Jinsheng Xu
    Yaling Bai
    Shenglei Zhang
    Meijuan Cheng
    Jingjing Jin
    Investigational New Drugs, 2021, 39 : 860 - 870
  • [5] Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis
    Li, Han
    Xu, Jinsheng
    Bai, Yaling
    Zhang, Shenglei
    Cheng, Meijuan
    Jin, Jingjing
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (03) : 860 - 870
  • [6] Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma
    Patrinely, James R., Jr.
    Baker, Laura X.
    Davis, Elizabeth J.
    Song, Haocan
    Ye, Fei
    Johnson, Douglas B.
    CANCER, 2020, 126 (15) : 3448 - 3455
  • [7] Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens
    Song, Mengjia
    Chen, Xinfeng
    Wang, Liping
    Zhang, Yi
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (02) : 157 - 172
  • [8] Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens
    Mengjia Song
    Xinfeng Chen
    Liping Wang
    Yi Zhang
    Chinese Journal of Cancer Research, 2018, 30 (02) : 157 - 172
  • [9] Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma
    Chen, Jiaqi
    Zhang, Ding
    Yuan, Ying
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (03) : 579 - 590
  • [10] Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma
    Jiaqi Chen
    Ding Zhang
    Ying Yuan
    Clinical and Experimental Medicine, 2023, 23 : 579 - 590
12345